Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Published: April 1st 2004 | Updated:

Trending on AJMC

Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review

Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success

US, Japan Patients With Diabetes Discontinue Semaglutide After First Year

How Clinician-Led Partnerships Strengthen Post-Acute Care

FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.